Introduction: Vitamin K antagonist (VKA) treatment requires routine monitoring using the international normalized ratio (INR). However, different INR assays may vary in their results. The aim of this study was to assess the agreement of three different INR methods, compared with thrombin generation, in patients on VKA treatment. Methods: Sixty patients attending the Anticoagulation Clinic at Mater Dei Hospital (Msida, Malta) for VKA monitoring between August and September 2015 were enrolled. The INR was tested using a point-of-care (POC) device (CoaguChek XS Plus, Roche Diagnostics) for both capillary and venous blood samples, a photo-optical (Sysmex CS-2100i/CA-1500, Siemens) and a mechanical clot detection system (Thrombolyzer XRC, Behnk ...
Copyright © 2013 Mina Hur et al. is is an open access article distributed under the Creative Commons...
Vitamin K antagonists (VKA) are frequently used anticoagulants. They are very effective in preventin...
Coagulation status with vitamin K antagonists (VKAs) needs to be monitored carefully to ensure maxim...
Introduction: Vitamin K antagonist (VKA) treatment requires routine monitoring using the internation...
Point of care testing (POCT) international normalized ratio (INR) devices are widely accepted for se...
CONTEXT: Anticoagulation with warfarin is considered the appropriate treatment for venous thromboemb...
Background: It is unknown whether patients with hemophilia A with atrial fibrillation require treatm...
Vitamin K antagonists, such as warfarin, have a narrow therapeutic window; patients on these therapi...
BACKGROUND: Procedures requiring optimisation of the coagulation status of patients using vitamin K ...
Atrial fibrillation is preventable cause for ischemic stroke and various other thrombo-embolic event...
STUDY OBJECTIVE: To determine if a fixed dose of 1000 IU of 4-factor prothrombin complex concentrate...
BACKGROUND: The standardized test used for evaluating the effect of warfarin is the prothrombin time...
The efficacy and safety of vitamin K antagonists (VKA) are related to the actual level of anticoagul...
Background: The time in therapeutic range (TTR) of patients with venous thromboembolism (VTE) treate...
INTRODUCTION: There is currently little evidence for the optimal dosing strategy of four-factor prot...
Copyright © 2013 Mina Hur et al. is is an open access article distributed under the Creative Commons...
Vitamin K antagonists (VKA) are frequently used anticoagulants. They are very effective in preventin...
Coagulation status with vitamin K antagonists (VKAs) needs to be monitored carefully to ensure maxim...
Introduction: Vitamin K antagonist (VKA) treatment requires routine monitoring using the internation...
Point of care testing (POCT) international normalized ratio (INR) devices are widely accepted for se...
CONTEXT: Anticoagulation with warfarin is considered the appropriate treatment for venous thromboemb...
Background: It is unknown whether patients with hemophilia A with atrial fibrillation require treatm...
Vitamin K antagonists, such as warfarin, have a narrow therapeutic window; patients on these therapi...
BACKGROUND: Procedures requiring optimisation of the coagulation status of patients using vitamin K ...
Atrial fibrillation is preventable cause for ischemic stroke and various other thrombo-embolic event...
STUDY OBJECTIVE: To determine if a fixed dose of 1000 IU of 4-factor prothrombin complex concentrate...
BACKGROUND: The standardized test used for evaluating the effect of warfarin is the prothrombin time...
The efficacy and safety of vitamin K antagonists (VKA) are related to the actual level of anticoagul...
Background: The time in therapeutic range (TTR) of patients with venous thromboembolism (VTE) treate...
INTRODUCTION: There is currently little evidence for the optimal dosing strategy of four-factor prot...
Copyright © 2013 Mina Hur et al. is is an open access article distributed under the Creative Commons...
Vitamin K antagonists (VKA) are frequently used anticoagulants. They are very effective in preventin...
Coagulation status with vitamin K antagonists (VKAs) needs to be monitored carefully to ensure maxim...